For pharmaceutical formulators, nutraceutical developers, and contract manufacturing organizations, the selection of an appropriate capsule delivery system is a foundational decision that impacts drug stability, patient compliance, and product differentiation. Capsules remain one of the most widely accepted oral dosage forms globally, offering advantages over tablets including ease of swallowing, formulation flexibility for moisture-sensitive actives, and the ability to combine multiple ingredients in a single unit. Traditional gelatin capsules, while effective, face limitations for vegetarian consumers and with certain moisture-sensitive formulations. The evolution of plant-based capsule technologies—including hydroxypropyl methylcellulose (HPMC) and emerging algal-derived materials—has expanded formulation options, enabling targeted release profiles, improved stability, and clean-label positioning. As the global market for both prescription pharmaceuticals and over-the-counter supplements continues to grow, with increasing demand for vegetarian, vegan, and specialty release formulations, the empty capsule market has expanded significantly. Addressing these formulation and consumer imperatives, Global Leading Market Research Publisher QYResearch announces the release of its latest report “Pharmaceutical and Nutraceutical Empty Capsules – Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032”. This comprehensive analysis provides stakeholders—from pharmaceutical formulators and nutraceutical developers to contract manufacturing organizations and healthcare investors—with critical intelligence on a capsule category that is fundamental to the delivery of oral solid dosage forms across pharmaceutical and supplement markets.
【Get a free sample PDF of this report (Including Full TOC, List of Tables & Figures, Chart)】
https://www.qyresearch.com/reports/6098139/pharmaceutical-and-nutraceutical-empty-capsules
Market Valuation and Growth Trajectory
The global market for Pharmaceutical and Nutraceutical Empty Capsules was estimated to be worth US$ 2,935 million in 2025 and is projected to reach US$ 4,417 million, growing at a CAGR of 6.1% from 2026 to 2032. In 2024, global sales volume reached 1,210 billion capsules, with an average price of US$ 23.5 per 10,000 capsules. This steady growth trajectory reflects the expanding global pharmaceutical and nutraceutical markets, increasing demand for vegetarian and plant-based dosage forms, and the growing adoption of specialty release capsule technologies.
Product Fundamentals and Technological Significance
Pharmaceutical and nutraceutical empty capsules are hollow capsule dosage forms specifically designed to encapsulate pharmaceuticals or dietary supplements. They can be made from gelatin, hydroxypropyl methylcellulose (HPMC), or other edible plant-based polysaccharides. These capsules offer excellent biocompatibility, chemical stability, and controlled dissolution properties, protecting active ingredients from light, oxygen, moisture, and gastric acid to ensure the stability and efficacy of the drug or nutritional component. Pharmaceutical capsules are mainly used for oral prescription and over-the-counter drugs, while nutraceutical capsules deliver vitamins, minerals, probiotics, and functional food ingredients. Depending on formulation requirements, they can be designed as immediate-release, sustained-release, or enteric-coated forms to achieve specific release sites and timing.
The capsule dosage form offers distinct advantages over other oral solid dosage forms. For formulators, capsules provide flexibility in delivering complex formulations including liquids, semi-solids, and multi-particulate systems that cannot be compressed into tablets. For moisture-sensitive active pharmaceutical ingredients (APIs) such as probiotics, enzymes, and certain small molecules, capsules offer superior protection compared to tablets, which require exposure to moisture during compression and coating. For patients, capsules are often easier to swallow than tablets, improving compliance, particularly among pediatric and geriatric populations. The evolution of capsule materials has expanded formulation options: traditional gelatin capsules remain the standard for many applications, offering proven stability and low cost; HPMC capsules provide an alternative for vegetarian consumers and offer lower moisture content (3-7% vs. 13-16% for gelatin), making them suitable for moisture-sensitive fills; emerging algal-based capsules offer natural acid resistance, enabling delayed-release formulations without additional enteric coating.
Market Segmentation and Application Dynamics
Segment by Type (Capsule Size):
- 00# — Represents the largest size, used for high-dose pharmaceuticals and large-volume nutraceutical formulations.
- 0# — Represents a commonly used size for prescription drugs and premium supplements, balancing dose capacity with swallowing convenience.
- 1# — Represents a mid-size capsule widely used for both pharmaceutical and supplement applications.
- 2# — Represents a smaller size for lower-dose formulations and pediatric applications.
- 3# — Represents a small-size capsule for low-dose actives and specialty applications.
- Others — Includes size 4, size 5, and specialty sizes for specific applications.
Segment by Application:
- Pharmaceuticals — Represents a significant segment for prescription drugs, over-the-counter medications, and specialty pharmaceutical products. Pharmaceutical applications demand stringent quality control, stability data, and regulatory compliance with pharmacopoeial standards (USP, EP, JP).
- Health Supplements — Represents the largest and fastest-growing segment, encompassing vitamins, minerals, herbal supplements, probiotics, and functional ingredients. The supplement market drives demand for vegetarian/vegan capsules, clean-label formulations, and specialty release technologies.
- Others — Includes nutraceuticals, functional foods, and emerging applications.
Competitive Landscape and Geographic Concentration
The pharmaceutical and nutraceutical empty capsule market features a competitive landscape dominated by global capsule manufacturers with established pharmaceutical quality systems and significant production capacity. Key players include Qualicaps, Lonza, ACG Associated Capsules, Suheung, CapsCanada, Sunil Healthcare, Evonik Specialty Chemicals, Shandong Healsee Capsule, Anhui Huangshan Capsule, Farmacapsulas, Guangzhou Jiuzhou Capsule, Hunan Er-Kang Pharmaceutical, Hebei Kangxin Plant Capsule, Zhejiang Yueshan Capsule, Zhejiang Tianlong Capsule, Zhejiang Xinchang Kangping Capsule, Jiangsu Kangyoujian Biotechnology, Guizhou Guang De Li Pharmaceuticals, SUZHOU CAPSUGEL, Chongqing Heng Sheng Pharmaceutical, Jiangsu Youli Capsule, Jinan Gaohua Medicinal Capsule, Qingdao Gather Great Ocean Algae Industry Group, and GoCaps GmbH.
A distinctive characteristic of this market is the geographic concentration of capsule manufacturing in Asia, particularly China and India, alongside European and North American manufacturers serving premium and specialty markets. Lonza (formerly Capsugel) and Qualicaps represent the global leaders with comprehensive product portfolios covering gelatin, HPMC, and specialty capsules, regulatory expertise, and worldwide distribution networks. ACG Associated Capsules and Suheung represent strong Asian competitors with significant manufacturing capacity. Chinese manufacturers—including Shandong Healsee, Anhui Huangshan, and Zhejiang Yueshan—have captured significant domestic and export market share through cost-competitive offerings and capacity expansion, serving the rapidly growing Chinese pharmaceutical and supplement markets.
Exclusive Industry Analysis: The Divergence Between Pharmaceutical and Nutraceutical Capsule Strategies
An exclusive observation from our analysis reveals a fundamental divergence in capsule sourcing and development strategies between pharmaceutical and nutraceutical applications—a divergence that reflects different regulatory requirements, stability considerations, and market dynamics.
In pharmaceutical applications, capsule selection is driven by regulatory compliance, stability documentation, and supply chain security. A case study from a global pharmaceutical manufacturer illustrates this segment. The manufacturer specifies gelatin capsules for a portfolio of oral solid products, requiring DMF documentation, stability support, and validated manufacturing processes. The manufacturer works with established global suppliers with proven quality systems and regulatory expertise, prioritizing supply reliability and documented quality over cost optimization.
In nutraceutical applications, capsule selection balances formulation requirements with market positioning, cost efficiency, and supply chain flexibility. A case study from a large dietary supplement brand illustrates this segment. The brand uses both gelatin and HPMC capsules across its product line, selecting HPMC for vegetarian products and gelatin for standard formulations. The brand works with multiple capsule suppliers to ensure competitive pricing and supply chain resilience, with shorter qualification cycles and greater emphasis on cost and service than pharmaceutical applications.
Technical Challenges and Innovation Frontiers
Despite market maturity, empty capsules face persistent technical challenges. Formulation compatibility with diverse fill materials—including oils, semi-solids, and hygroscopic powders—requires ongoing development of capsule materials and manufacturing processes. Advanced capsule technologies including liquid-filled hard capsules and self-emulsifying formulations are expanding application possibilities.
Enteric coating technologies for targeted delivery require specialized capsule formulations and coating systems. Advanced capsule materials with inherent acid resistance, such as algal-based capsules, are simplifying delayed-release formulations.
A significant technological catalyst emerged in early 2026 with the commercial validation of HPMC capsules with integrated sustained-release properties, enabling controlled drug delivery without separate coating or multi-particulate systems. These advanced capsules simplify manufacturing and enable new formulation approaches for once-daily dosing.
Policy and Regulatory Environment
Recent policy developments have influenced market trajectories. USP and EP monographs for gelatin and HPMC capsules establish quality standards for pharmaceutical applications. Clean-label and natural product trends in the dietary supplement market drive demand for plant-based capsule options. Vegetarian and vegan labeling requirements in various markets influence capsule material selection for supplement products.
Regional Market Dynamics and Growth Opportunities
Asia-Pacific represents the largest and fastest-growing market for empty capsules, driven by China’s dominant pharmaceutical and supplement manufacturing base, India’s expanding pharmaceutical sector, and growing domestic consumption of dietary supplements. North America and Europe represent significant markets, with strong demand for vegetarian/vegan dosage forms, premium supplement products, and specialty pharmaceutical applications.
For pharmaceutical formulators, nutraceutical manufacturers, contract manufacturing organizations, and healthcare investors, the pharmaceutical and nutraceutical empty capsule market offers a compelling value proposition: steady growth driven by pharmaceutical and supplement market expansion, essential dosage form for oral delivery, and innovation opportunities in plant-based materials and specialty release technologies.
Contact Us:
If you have any queries regarding this report or if you would like further information, please contact us:
QY Research Inc.
Add: 17890 Castleton Street Suite 369 City of Industry CA 91748 United States
EN: https://www.qyresearch.com
E-mail: global@qyresearch.com
Tel: 001-626-842-1666(US)
JP: https://www.qyresearch.co.jp
